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Abstract
Preterm infants are obviously born lighter and shorter, with smaller head circumferences than normal birth weight
term born neonates. They also have a different body composition. Compromised growth is associated with adverse
health outcomes. Both growth retardation and accelerated growth are suggested to cause metabolic, cardiovascular,
and renal complications. Reviews regarding growth and body composition in preterm infants often do not differen-
tiate between birth weight and gestational age. The purpose of this systematic review is to assemble growth data,
specific in extremely low birth weight children. Different databases were searched for studies regarding growth and
body composition in former extremely low birth weight infants until adulthood. We compared height, weight, head
circumference, body mass index, fat mass, lean mass, fat distribution, and body water to matched normal birth
weight controls and the World Health Organization growth charts. Studies consistently reported that former extreme-
ly low birth weight neonates experience a period of accelerated postnatal growth, but they achieve lower anthropo-
metric parameters than normal birth weight children. There is no consensus about differences in body composition
and how to measure this.
Conclusion: Although extremely low birth weight infants exhibit a period of catch-up growth, their growth remains retarded
later in life. Further research is needed to investigate body composition and the associated risk of cardiovascular diseases or
metabolic syndrome.
What is Known:
• Extremely low birth weight infants have lower anthropometric parameters and a different body composition at birth and term-corrected age than
normal birth weight infants.
• Former extremely low birth weight infants also have a higher risk on adverse cardiovascular health outcomes in later life.
What is New:
• After hospital discharge, extremely low birth weight neonates remain smaller and probably also lighter, with smaller head circumferences at each
corrected age throughout childhood and adolescence when compared to normal birth weight infants or theWorld Health Organization growth charts.
It is not clear whether extremely low birth weight infants reach a lower or similar body mass index score as normal birth weight infants.
• There is a lack of (long-term) information on body composition in extremely low birth weight infants.
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LM Lean mass
LMI Lean mass index
%LM Percentage lean mass
NBW Normal birth weight
TBF Total body fat
%TBF Percentage total body fat
TBW Total body water
%TBW Percentage total body water
SGA Small for gestational age
TCA Term corrected age
WHO World Health Organization
SSE Sum of squared estimate of errors
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Introduction
Growth patterns and body development are relevant in pre-
term infants, likely most relevant in extremely low birth
weight (ELBW, i.e., <1 kg) infants. Infants born preterm are
lighter and shorter, with a smaller head circumference (HC)
than their term born normal birth weight (NBW) peers, at birth
as well as when they reach term-corrected age (TCA) and
throughout childhood [1, 2]. When preterm infants are classi-
fied by weight, as ELBW infants, they are often small for their
gestational age (SGA) [3]. This makes them even more sus-
ceptible to effects of perinatal growth retardation [4].
The perinatal growth retardation is followed by a period of
catch-up growth, which usually starts in early infancy and can
continue into early adolescence [5].
Preterm infants do not only have aberrant growth measure-
ments but they also have a different body composition com-
pared to term born neonates. Because the third trimester is a
period of rapid adipose tissue deposition, they exhibit a fat
distribution at TCA different than that of term born neonates.
Preterm infants have a lower fat mass (FM) and an even more
decreased lean mass (LM) at TCA, resulting in a greater per-
centage total body fat (%TBF) than term born infants [2].
Low birth weight (LBW) infants, and even more ELBW
infants are more susceptible to coronary heart diseases, neo-
natal acute kidney injury, chronic kidney disease, type 2 dia-
betes, stroke, and hypertension [6–8].
Although the effects of (early) infancy weight gain on later
body composition and health outcomes are not clear, associa-
tions with an aberrant fat distribution, cardiovascular diseases,
and an obesity-associated exacerbation of renal risk have been
suggested [8–12]. It is suggested that an altered body compo-
sition that persists into adulthood could be a risk factor for
developing metabolic and cardiovascular diseases, although
it could not always be identified as a causal factor [3, 5, 9,
13, 14]. However, the ideal growth pattern for ELBW infants
is not yet known.
In addition, analyzing body composition could be useful
for calculating drug doses and body composition parameters
are used in some prediction models to determine maintenance
doses [15].
Literature reviews regarding body composition after hospi-
tal discharge and later in life are scarce and most do not dif-
ferentiate between gestational age (GA) or birth weight (BW),
although they might be important predictors of body compo-
sition [16].
This systematic search focuses specifically on ELBW in-
fants and investigates their growth patterns and body compo-
sition after hospital discharge throughout infancy and adult-
hood. Using a systematic review approach, we compared
height, weight, HC, and body mass index (BMI) to control
data of NBW peers and growth charts described by the World
Health Organization (WHO) and the Canadian Pediatric
Endocrine Group (CPEG). Parameters regarding body fat
and fat distribution were compared to control data in the in-
cluded studies.
Materials and methods
Study characteristics
Study design
We performed a systematic search and review including both
prospective and retrospective longitudinal studies, as well as
cross-sectional studies that describe data in cohorts of former
ELBW neonates after hospital discharge until adulthood.
There was no limit on minimum or maximum follow-up time.
We only included observational studies. Intervention studies
were excluded.
Language restrictions
Besides studies and abstracts that were available in English,
studies written in a different language were included if they
had an abstract or schematics available in English that
contained the desired data.
Patients
We included studies concerning former ELBW infants.
ELBW is defined as a BW less than 1000 g. ELBW infants
are either SGA or appropriate for their GA (AGA). SGA is
defined as a BW less than the 10th percentile for weight given
the GA [17–22], but studies are heterogeneous as they some-
times use different terms and definitions to indicate SGA.
Intra-uterine growth restriction is also used as an analogous
definition.
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For control data, we simultaneously collected the data of
control NBW (i.e., 2500–4000 g) infants matched by sex and
age in the concerned study whenever available, and we com-
pared the growth parameters to the WHO and CPEG growth
charts [23–25].
Search strategy and selection process
A first search was performed by the first author in July 2018
and a second one in December 2018. Databases PubMed,
Cochrane Library, Web of Science, and Embase were
searched.
The extended search strategies for different databases and
selection of the articles are represented in Table 1 and Fig. 1,
respectively [26]. The quality of the English studies was
assessed using the “Quality Assessment Tool for
Observational Cohort and Cross-Sectional Studies” of the
National Heart, Lung and Blood Institute [27]. Studies were
selected based on title and abstract, and the second author was
consulted in case of uncertainties.
Outcome parameters and methodology applied
Parameters that were a component of growth or body compo-
sition were extracted by the first author. In case of uncer-
tainties, the second author was consulted. Extracted growth
parameters are height, weight, HC, and BMI. Parameters re-
garding body composition were either absolute (i.e., FM, LM,
and total body water (TBW)) or relative (%TBF, percentage
leanmass (%LM), and percentage total body water (%TBW)).
We also investigated fat distribution.
Growth
We compared mean height, weight, HC, and BMI with data of
NBW control children when available in the studies and with
the 5th, 25th, and 50th percentile of the standard growth pa-
rameters as described in the WHO Child Growth Standards
and in the WHO Reference 2007 [23–25]. For weight-for-age
after the age of 10, we compared with extended WHO refer-
ence curves provided by the CPEG. Since these charts do not
provide data for the 5th percentile, we compared to the 3th
percentile instead [28].
We plotted the calculated weighted mean data of boys and
girls against the WHO growth charts. The WHO data were
calculated as the weighted mean of boys and girls equal to the
ratio of male to female patients in the concerned studies at the
compared age. We plotted growth data in graphs edited in
MATLAB, while using a rational function based on the en-
tered data [29]. Individual function characteristics of the
graphs are described below the figures. The WHO growth
charts are used to describe trends among the growth of
ELBW infants, but they were not statistically compared with
the study data.
Different definitions of catch-up growth are used in the
included studies. Catch-up growth is defined as a positive
increase of the Z-score of >0.67 over a certain period of time
[20, 30] or reaching growth parameters more than −2 SD
scores for age [22, 31].
Body composition
For FM, LM, %TBF, and %LM, we compared mean data of
ELBW infants to control data as described in the included
studies.
Methods to measure growth parameters and body
composition
Studies were not excluded based on methods used for mea-
suring growth parameters or body composition, as some of
these methods are suggested to bemore accurate but alsomore
expensive or less applicable to newborn infants [14]. The use
of these methodologies is further explained in the studies.
Results
There were 486 search results in PubMed, 33 trials in
Cochrane Library, 383 in Embase, and 192 in Web of
Science. Two studies that met the selection criteria were ex-
cluded to avoid duplication (the study populations were also
included in another more comprehensive included study) [32,
33]. Eventually, a total of 16 studies and one abstract were
included. The selection process of the articles is represented in
the PRISMA flow chart in Fig. 1 [26]. An overview of the
included studies and the quality assessment are represented in
Table 2 and Table 3, respectively. One study had a very low
follow-up rate with a small remaining study sample and was
therefore not used for the WHO comparison [38]. Results of
growth compared to controls are represented in Table 4 and
those of body composition data in Table 5.
Growth
Height
In almost every included study that compared ELBW infants
to NBW infants, children and adults born with an ELBW
remain smaller than NBW children, at every stage of their
development [17–21, 30, 35–37, 39–41]. Two studies found
a difference between genders with a lower height in male
infants at the age of 11 [41] and in female infants at the age
of 14.7 [20]. Two studies suggested that ELBW infants attain
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Table 1 Search strategies for different databases
Database Search strategy
Pubmed (("Extremely Low Birth Weight Infant"[Mesh] OR “Extremely low birth weight infant*”[tiab] OR “ELBW”[tiab] OR “Extremely Low Birth
Weight”[tiab])) AND (“Body Constitution"[Mesh/NoExp] OR “Body Constitution*"[tiab] OR “Body Distribution”[tiab] OR “Body weights and
measures”[Mesh/NoExp] OR “body weights and measures”[tiab] OR “BodyMeasure*”[tiab] OR “morphometry”[tiab] OR “Morphometrics”[tiab] OR
“Body Fat Distribution”[Mesh] OR “Body Fat Distribution”[tiab] OR “Body Fat Patterning”[tiab] OR “Adiposity”[tiab] OR “Adipose tissue
distribution”[tiab] OR “Fat tissue distribution”[tiab] OR “Fatty Tissue Distribution”[tiab] OR “BodyMass Index”[Mesh] OR “BodyMass Index”[tiab]
OR “Quetelet* Index”[tiab] OR “BMI”[tiab] OR “Body Size”[Mesh/NoExp] OR “Body Size*”[tiab] OR “Body Mass”[tiab] OR “Body
Height”[Mesh/NoExp] OR “Body Height*”[tiab] OR “Body length”[tiab] OR“Body Weight”[Mesh/NoExp] OR “Body Weight*”[tiab] OR “Total
Body Weight”[tiab] OR “Body Weight Changes”[Mesh/NoExp] OR “Body Weight Change*”[tiab] OR “Body Composition”[Mesh] OR “Body
Composition*”[tiab] OR “Body Water”[mesh] OR “body water”[tiab] OR “Whole Body Water”[tiab] OR “Total Water”[tiab] OR “Total Body
Water”[tiab] OR “Total Body Fluid”[tiab] OR “adipose tissue”[Mesh/NoExp] OR “Adipose Tissue*”[tiab] OR “Fat Tissue”[tiab] OR “Fatty
Tissue”[tiab] OR “Fat Pad*”[tiab] OR “Body Fat”[tiab] OR “body lipid”[tiab] OR “visceral fat distribution”[tiab] OR “Subcutaneous Fat
distribution”[tiab] OR “Anthropometry”[Mesh/NoExp] OR “Anthropometry”[tiab] OR “Anthropometric index”[tiab] OR “Anthropometrics”[tiab] OR
“Anthropometric parameters”[tiab] OR “Cephalometry”[mesh] OR “Cephalometry”[tiab] OR “Cephalometrics”[tiab] OR “Craniometry”[tiab] OR
“Craniometrics”[tiab] OR “Head circumference”[tiab] OR “Cranial Circumference”[tiab] OR “Fat Mass”[tiab] OR “Fat Free Mass”[tiab] OR “Lean
Mass”[tiab] OR (“Postdischarge”[tiab] or “Postdischarge”[ tiab] AND (“growth”[mesh] OR “growth”[tiab])))
Cochrane
Library
#1[mh “Extremely Low Birth Weight Infant”]
#2(“Extremely low Birth Weight Infant” or “ELBW” or “Extemely low birth weight”):ti,ab,kw
#3#1 OR #2
#4[mh ^”Body Constitution”] or [mh ^”BodyWeights and measures”] or [mh “Body Fat Distribution”] or [mh “BodyMass Index”] or [mh ^”Body Size”]
or [mh ^”Body Height”] or [mh ^”Body Weight”] or [mh ^”Body Weight Changes”] OR [mh “Body Composition”] or [mh “Body Water”] or [mh
^”Adipose tissue”] or [mh ^”Anthropometry”] or [mh “Cephalometry”]
#5(“Body Constitution” or “Body Distribution” or “body weights and measures” or “Body Measure*” or “morphometry” or “Morphometrics” or “Body
Fat Distribution” or “Body Fat Patterning” or “Adiposity” or “Adipose tissue distribution” or “Fat tissue distribution” or “Fatty Tissue Distribution” or
“BodyMass Index” or “Quetelet* Index” or “BMI” or “Body Size*” or “BodyMass” or “BodyHeight*” or “Body length” or “BodyWeight*” or “Total
BodyWeight” or “BodyWeight Change*” or “BodyComposition*” or “bodywater” or “Whole BodyWater” or “TotalWater” or “Total BodyWater” or
“Total Body Fluid” or “Adipose Tissue*” or “Fat Tissue” or “Fatty Tissue” or “Fat Pad*” or “Body Fat” or “body lipid” or “visceral fat distribution” or
“Subcutaneous Fat distribution” or “Anthropometry” or “Anthropometric index” or “Anthropometrics” or “Anthropometric parameters” or
“Cephalometry” or “Cephalometrics” or “Craniometry” or “Craniometrics” or “Head circumference” or “Cranial Circumference” or “Fat Mass” or “Fat
Free Mass” or “Lean Mass”):ti,ab,kw
#6(“Postdischarge” or “Post-Discharge”):ti,ab,kw
#7[mh ^”Growth”]
#8(“Growth”):ti,ab,kw
#9#7 OR #8
#10#6 and #9
#11#5 OR #10
#12#4 OR #11
#13#3 AND #12
EMBASE (‘extremely low birth weight’/exp. OR ‘extremely low birth weight’:ti,ab OR ‘elbw’:ti,ab OR ‘extremely low birth weight infant*’:ti,ab) AND (‘body
constitution’/exp. OR ‘body constitution’:ti,ab OR ‘body distribution’:ti,ab OR ‘morphometry’/mj OR ‘morphometry’:ti,ab OR ‘morphometrics’:ti,ab
OR ‘body weights and measures’:ti,ab OR ‘body measure*’:ti,ab OR ‘body composition’/exp. OR ‘body composition’:ti,ab OR ‘body fat’:ti,ab OR
‘body lipid’:ti,ab OR ‘fat load’:ti,ab OR ‘body fat distribution’:ti,ab OR ‘body fat patterning’:ti,ab OR ‘adipose tissue distribution’:ti,ab OR ‘fat tissue
distribution’:ti,ab OR ‘fatty tissue distribution’:ti,ab OR ‘subcutaneous fat distribution’:ti,ab OR ‘visceral fat distribution’:ti,ab OR ‘body water’:ti,ab
OR ‘total water’:ti,ab OR ‘whole body water’:ti,ab OR ‘total body water’:ti,ab OR ‘total body fluid’:ti,ab OR ‘adipose tissue’/mj OR ‘adipose
tissue’:ti,ab OR ‘fat tissue’:ti,ab OR ‘fatty tissue’:ti,ab OR ‘fat pad’/exp. OR ‘fat pad*’:ti,ab OR ‘anthropometry’/mj OR ‘anthropometry’:ti,ab OR
‘anthropometric index’:ti,ab OR ‘anthropometrics’:ti,ab OR ‘antropometry’:ti,ab OR ‘body measurement’:ti,ab OR ‘cephalometry’/mj OR
‘cephalometry’:ti,ab OR ‘cephalometrics’:ti,ab OR ‘head size’:ti,ab OR ‘craniometry’/mj OR ‘craniometry’:ti,ab OR ‘craniometrics’:ti,ab OR
‘anthropometric parameters’/mj OR ‘anthropometric parameters’:ti,ab OR ‘body height’/exp. OR ‘body height’:ti,ab OR ‘body length’:ti,ab OR ‘body
weight’/mj OR ‘body weight’:ti,ab OR ‘total body weight’:ti,ab OR ‘body weight change*’:ti,ab OR ‘body mass’/exp. OR ‘body mass’:ti,ab OR
‘bmi’:ti,ab OR ‘body mass index’:ti,ab OR ‘quetelet* index’:ti,ab OR ‘body size’/exp. OR ‘body size’:ti,ab OR ‘fat free mass’/exp. OR ‘fat free
mass’:ti,ab OR ‘fat mass’/exp. OR ‘fat mass’:ti,ab OR ‘lean mass’:ti,ab OR ‘head circumference’/exp. OR ‘head circumference’:ti,ab OR ‘cranial
circumference’:ti,ab OR ((‘postdischarge’:ti,ab OR ‘post-discharge’:ti,ab) AND (‘growth’/mj OR ‘growth’:ti,ab)))
Web of Science TS = ((“Extremely low birth weight infant*”OR “ELBW” OR “Extremely Low Birth Weight”) AND (“Body Constitution*”OR “Body Distribution”OR
“body weights and measures”OR “BodyMeasure*”OR “morphometry”OR “Morphometrics”OR “Body Fat Distribution”OR “Body Fat Patterning”
OR “Adiposity” OR “Adipose tissue distribution” OR “Fat tissue distribution” OR “Fatty Tissue Distribution” OR “Body Mass Index” OR “Quetelet*
Index” OR “BMI” OR “Body Size*” OR “Body Mass” OR “Body Height*” OR “Body length” OR “Body Weight*” OR “Total Body Weight” OR
“BodyWeight Change*”OR “Body Composition*”OR “body water” OR “Whole BodyWater”OR “Total Water” OR “Total BodyWater”OR “Total
Body Fluid”OR “Adipose Tissue*”OR “Fat Tissue”OR “Fatty Tissue”OR “Fat Pad*”OR “Body Fat”OR “body lipid”OR “visceral fat distribution”
OR “Subcutaneous Fat distribution” OR “Anthropometry” OR “Anthropometric index” OR “Anthropometrics” OR “Anthropometric parameters” OR
“Cephalometry” OR “Cephalometrics” OR “Craniometry” OR “Craniometrics” OR “Head circumference” OR “Cranial Circumference” OR “Fat
Mass” OR “Fat Free Mass” OR “Lean Mass” OR ((“Postdischarge” OR “Post-discharge”) AND “growth”)))
ELBWExtremely low birth weight, BMIBodymass index, Ti title, Ab abstract,MhMeSH,NoExp unexploded, Tiab title or abstract,Mjmajor focus, Exp
explode, TS top
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a normal height compared with the mean biparental predicted
height at 14, 15, and 20 years [36, 38].
When compared with the WHO growth charts,
ELBW infants seem to have a growth pattern almost
similar to the 25th percentile with some values around
the 5th percentile under the age of 1. Only a few stud-
ies found a height that was comparable with the 50th
percentile (Fig. 2).
Weight
Most studies agree that ELBW infants also remain ligh-
ter than NBW infants at each corrected age (CA)
[17–21, 30, 37, 39–41]. However, two studies did not
find a statistical significance between former ELBW and
NBW infants at the age of 14, 20 [36], and 34 [35].
One study described a lower weight in male patients
only at the age of 11 [41] and one in female patients
only at the age of 14.7 [20].
In their first 7 years of life, ELBW infants seem to have a
weight similar to the 25th percentile of the WHO growth
charts, with a trend toward the 50th percentile afterwards
(Fig. 3).
Head circumference
All studies investigating HC report that ELBW infants and
adolescents have a smaller HC than NBW control peers in
their childhood as well as when they reach adult age [18, 19,
30, 37, 39–41].
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The WHO growth charts only describe HC until the age of
5. During this period, the HC of ELBW infants seems to
fluctuate between the 25th and 50th percentile with a trend
toward the 25th percentile (Fig. 4).
Body mass index
Since both their height and weight are lower than that of
NBW children, it is still unclear whether former ELBW
Table 2 Overview of included studies
Authors and
reference
Study design Group N
(male/female)
Age (N) at assessment Mean GA
(weeks)
Mean BW (grams) Measuring
methods
Atkinson SA et al.
[34]
Longitudinal
cohort
ELBW 125 23.1 ± 1.4y (96) 7.1 ± 2.3 841 ± 125 DEXA
NBW 119 23.5 ± 1.2y (92) NA NA
Crane JD et al. [35] Cross-sectional
cohort
ELBW 29 (12/17) 34.3 ± 0.33y NA 830 ± 20 Harpenden
stadiometer
Electronic scale
MRI; DEXA
NBW 16 (7/9) 34.9 ± 0.32y NA 3330 ± 100
Doyle LW et al.
[36]
Longitudinal
cohort
ELBW 42 (15/27) Birth to 20.3 ± 1.0y
at 2y, 5y, 8y, 14y
27.4 ± 2.0 877 ± 86 Harpenden
stadiometer
Digital scale
Hack. et al. [20] Longitudinal
cohort
ELBW 148 (52/96) 8y (147); 14y (148) 26.5 ± 2 825 ± 119/813 ± 124 Infantometer;
stadiometerNBW 176 (65/111) 8y (176); 14y (115) ≥37 3323 ± 597/3238 ± 411
Hill AS et al. [37] Retrospective
cohort
ELBW 46 Birth; discharge; 6 m;
12 m;1 8 m
27.03 ± 1.75 796.22 ± 140.18 NA
Hirata T et al. [38] Longitudinal
cohort
ELBW 103 Follow-up from birth to
14.3 ± 1.8
(8)y / 15.6 ± 1.5y (15)
26.6 ± 1.4 818 ± 110 Standard balance
beam weight
scale with height
rod
Jordan IM et al.
[31]
Retrospective
cohort
ELBW 159 (82/77) Birth, TCA, 3 m, 9 m, 18 m,
36 m
28 ± 2 851.2 ± 116.5 NA
Kwinta P et al. [39] Cross-sectional
cohort
ELBW 81 (29/52) 6.7 ± 0.4y 27.2 ± 2.1 845 ± 130 Multifrequency
bioimpedanceNBW 39 (19/20) 6.9 ± 0.8y 39.9 ± 1.4 3554 ± 512
Lin YC et al. [40] Retrospective
cohort
ELBW 100 (41/59) 6 m (68), 12 m (67), 24 m (62) 26* 772* Standard procedure
Mól N et al. [41] Prospective
cohort
ELBW 81 (29/52) 6.61 ± 0.36y (81); 11.06 ± 0.38y
(62)
27.3 ± 2.3 843.3 ± 132.4 Standard medical
tape; fixed
stadiometer
Medical scale
(nearest 100 g)
NBW 36 (19/17) 6.98 ± 0.83y; 10.62 ± 0.82y 39.8 ± 1.4 3589.4 ± 538.8
Monset-Couchard
M et al. [22]
Longitudinal
cohort
ELBW 166 (64/102) Consistent follow-up from birth
to 18 years of age
NA NA NA
Morrison M et al.
[17]
Prospective
cohort
ELBW 100 (40/60) 31.63 ± 1.66y 27.10 ± 2.45 829.00 ± 130.38 Harpenden
stadiometer
Electronic scale
DEXA
NBW 89 (37/52) 31.96 ± 1.42y NA 3391.30 ± 442.28
Peralta-Carcelen M
et al. [18]
Cross-sectional
cohort
ELBW 53 (22/31) 14.8 ± 1.8y 28.2 ± 2.3 849 ± 109 DEXA
NBW 53 14.9 ± 1.7y >37 3355 ± 526
Raaijmakers A
et al. [30]
Longitudinal
case-control
ELBW 93 (49/44) Birth (140); 9 m (118); 24 m
(96); 11.3 ± 1.4y (93)
NA NA Bioelectrical
impedance
NBW 87 (43/44) 10.9 ± 1.3y NA NA
Rodríguez-Soriano
J et al. [21]
Longitudinal
cohort
ELBW 40 (23/17) 8.6 ± 1.8y 27.6* 845* Harpenden
stadiometerNBW 43 (25/18) 8.5 ± 1.8y NA NA
Saigal S et al. [19] Prospective
cohort
ELBW 147 (65/82) Birth (179); 1y (157); 2y (137);
3y (123); 8y (147); 14.1 ± 1.6y
(144); 23.3 ± 1.2y (147)
27.1 ± 2.3 841 ± 125 Calibrated scale
Balance beam scale
NBW 131 (59/72) 8y (145); 141.4 ± 1.3 (121);
23.6 ± 1.1y (131)
NA 3380 ± 475
Sices L et al. [42] Retrospective
cohort
ELBW 154 (71/83) Birth (154); 39.2 ± 3.0w (154);
4.4 ± 0.7 m (143); 8.6 ± 1.0 m
(138); 19.0 ± 1.2 m (151)
25.9 ± 1.8 768 ± 140 Harpenden
infantemeter
Health-o-Meter
Scale
N is the number of infants in the selected cohort used to determine the mean GA and BW
N at age of assessment was added when different from the initial cohort
ELBW extremely low birth weight, NBW normal birth weight, GA gestational age, w weeks, m months, y years BW birth weight, NA not available;
information could not be extracted from the study, DEXA dual-energy x-ray absorptiometry
* Standard deviation scores are missing in the study
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children achieve a BMI score that is equal to that of NBW
children and adolescents [17, 19, 20, 36], or if their BMI
will be lower [21, 30, 32, 39, 41]. One study found a
higher BMI score in ELBW infants, but this result did
not reach statistical significance when compared to
NBW control subjects [35].
Studies do not contain BMI data under the age of 6.7. By
age 8 years and afterwards, BMI scores of former ELBW
infants seem to reach values between the 50th and the 75th
percentile of the WHO growth charts (Fig. 5).
Catch-up growth patterns
Studies investigating catch-up growth commonly report
that ELBW infants experience a period of neonatal
growth failure from birth to TCA, which sometimes
continues until 8 months or even after 1 year of age.
This growth failure is followed by a period of catch-up
growth, especially for weight and height, which con-
tinues until adulthood [19, 20, 22, 35–38, 41, 42].
Studies do not uniformly agree on the time of onset of
catch-up growth for different growth parameters and the use
of different definitions makes it hard to compare the results.
Some found catch-up growth starting from the age of 2 years
[19], while others report catch-up growth in most subjects
before the age of 3 years [22, 31, 42].
Former ELBW infants seem to have a marked catch-up
growth inweight and height between the age of 8 and 14 years,
with a more pronounced increment in weight than in height.
During this period, there was also a marked catch-up growth
for BMI [19, 20, 36].
It is suggested that catch-up growth for weight and height
in the first 2 years of life or HC in the first 9 months is asso-
ciated with a lower %TBF at adolescence. Catch-up growth
for weight during childhood (2–11 years) was also associated
with a lower %TBF at young adolescence [30]. Hack et al.
however discuss that catch-up growth throughout infancy is
associated with measures of obesity at the age of 14 and is
therefore not beneficial [20].
SGA versus AGA
As the definition is based on a weight, a relevant portion
of ELBW infants are SGA, higher than infants born with a
NBW [18, 19]. After the age of 8.6 and afterwards, no
significant difference in height and weight remained be-
tween SGA and AGA infants, but SGA infants reached a
height significantly below target height at 11 years [21].
Only one study found a significantly smaller HC in SGA
ELBW infants compared to AGA ELBW infants at the
age of 14 [18].Ta
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Body composition
FM, LM, and relative body composition
Two studies report a lower %LM or lean mass index (LMI,
i.e., total lean mass/height2), with a higher %TBF and fat mass
index (FMI, i.e., total fat mass/height2) in ELBW infants [17,
30]. The third study found a higher%TBF inmale infants only
[34]. Otherwise, a fourth study found a significantly lower
absolute LM and FM, but also a lower %TBF in children born
with an ELBW at the age of 7 [39].
The fifth study found no significant difference in %TBF
and %LM between ELBWand NBW infants reaching the age
of 14. They conclude that ELBW infants have a lower FM and
LM, but that the relative body composition is similar to those
of NBW children [18] (Table 5).
There was no difference in body composition between
SGA and AGA ELBW infants [18, 30].
Fat distribution
Only one study and one abstract reported on fat distribution in
ELBWinfants with different results since ELBWinfants had a
higher portion of visceral adipose tissue deposition in one
study [34], and this higher portion was limited to the subcu-
taneous fat areas only in the other study [35]. The last report
also found higher proportions of pancreatic and liver fat in
ELBW infants reaching young adulthood, but an ELBW
was not an independent influencer of these fat fractions [35].
Body water
Two studies investigated body water in ELBW infants, with
contradictory results. One study found lower absolute TBW
but a higher %TBW in former ELBW infants [39], while the
other found no significant difference in %TBW between
ELBW and NBW infants [30].
Discussion
Children born as ELBW infants have a specific growth pattern
until birth and exhibit a different body composition at birth
and TCA than their NBW counterparts. Their compromised
growth may result in a body composition later in life that
differs from NBW children. Literature describing growth
and evolution of body composition after hospital discharge
and in later life, however, is scarce. Therefore, we performed
a systematic literature search regarding growth parameters and
body composition in former ELBW infants throughout child-
hood and adolescence.
Most studies state that ELBW infants remain smaller
and lighter than NBW infants at every stage of theirTa
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development. In two studies, ELBW infants attained their
predicted biparental target height [36, 38]. Although
catch-up growth is often described, ELBW infants still
attain lower growth parameters by the time they reach
adulthood. Since their growth restriction is expressed both
in weight and height, it is not clear whether their BMI at
teen and adult age significantly differs from that of NBW
infants or not. It is suggested that catch-up growth is more
pronounced for weight than for height (“stunting”),
resulting in infants being proportionally heavier for their
height, although former ELBW infants are never assumed
to have a significantly higher BMI score [20, 32, 36].
Fig. 2 Height for age. Height for age is plotted for ELBW infants. The
shaded areas represent the 5th–25th and 25–50th percentiles of the WHO
growth charts;ELBW function: General model Rat44: f(x) = (p1*x^4 +
p2*x^3 + p3*x^2 + p4*x + p5) /, (x^4 + q1*x^3 + q2*x^2 + q3*x + q4),
Coefficients (with 95% confidence bounds): p1 = 204.5 (−159.7,
568.8), p2 = −2524 (−1.05e+04, 5452), p3 = −2966 (−2.332e+05,
2.272e+05), p4 = 5.533e+05 (−4.751e+06, 5.858e+06), p5 = 1.924e+05
(−1.825e+06, 2.21e+06), q1 = 2.602 (−197.4, 202.6), q2 = −432.9
(−5454, 4588), q3 = 6270 (−5.07e+04, 6.324e+04), q4 = 4312
(−4.087e+04, 4.95e+04), Goodness of fit: SSE: 36.72;R2: 0.999;
Adjusted R2: 0.9984; RMSE: 1.62; SSE sum of squared estimate of errors,
RMSE root mean square error
Fig. 3 Weight for age. Weight for age is plotted for ELBW infants. The
shaded areas represent the 5th–25th and 25th–50th percentiles of the
WHO/CPEG growth charts and the 3th–25th percentiles of the extended
charts provided by the CPEG; ELBW function: General model Rat45:
f(x) = (p1*x^4 + p2*x^3 + p3*x^2 + p4*x + p5) /; (x^5 + q1*x^4 +
q2*x^3 + q3*x^2 + q4*x + q5); where x is normalized by mean 9.043
and std. 10.21; Coefficients (with 95% confidence bounds): p1 =
5.146e+06 (−3.084e+11, 3.084e+11); p2 = 9.356e+06 (−5.607e+11,
5.607e+11); p3 = 4.198e+06 (−2.516e+11, 2.516e+11); p4 = 9.184e+05
(−5.504e+10, 5.505e+10); p5 = 8.684e+05 (−5.204e+10, 5.204e+10);
q1 = 4.386e+04 (−2.628e+09, 2.628e+09); q2 = 1.847e+05 (−1.107e+
10, 1.107e+10); q3 = 7.957e+04 (−4.768e+09, 4.768e+09); q4 =
−1.152e+04 (-6.898e+08, 6.898e+08); q5 = 3.429e+04 (−2.055e+09,
2.055e+09); Goodness of fit: SSE: 32.65; R2: 0.9972; Adjusted R2:
0.9949; RMSE: 1.723; SSE sum of squared estimate of errors, RMSE root
mean square error
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Former ELBW infants do not only reach a lower target
height and weight at every CA but they also have a smaller
HC. It has been suggested that a smaller HC is related to
poorer cognitive outcomes [43–45], but one study investigat-
ing neurodevelopment did not find an association between
catch-up growth for HC and neurocognitive outcome [30].
When comparing with theWHO growth charts, we came to
similar results, especially for height and HC. ELBW infants
seem to attain a height around the 25th percentile at young
adult age. Their HC also seems to be around the 25th percen-
tile. In the first 7 years of life, their weight and BMI remain
around the 25th percentile with afterwards a trend toward the
50th percentile. Their BMI seems to reach values between the
50th and the 75th percentile by young adulthood.
In the studies that linked catch-up growth to adverse health
outcomes, there is no consensuswhether early catch-up growth is
Fig. 4 Head circumference for age. Head circumference for age is plotted
for ELBW infants. The shaded areas represent the 5th–25th and 25–50th
percentiles of the WHO growth charts; ELBW function: General model
Rat24: f(x) = (p1*x^2 + p2*x + p3) / ; (x^4 + q1*x^3 + q2*x^2 + q3*x +
q4); Coefficients (with 95% confidence bounds): p1 = −4439 (−3.263e+
05, 3.174e+05); p2 = 1.478e+06 (−4.638e+06, 7.593e+06); p3 = 4.502e+
05 (−1.222e+06, 2.123e+06); q1 = 32.91 (−70.88, 5.063); q2 = 27.98
(−7218, 7274); q3 = 2.934e+04 (−9.444e+04, 1.531e+05); q4 = 1.349e+
04 (−3.662e+04, 6.359e+04); Goodness of fit: SSE: 5.773; R2: 0.99;
Adjusted R2: 0.9845; RMSE: 0.7244; SSE sum of squared estimate of
errors, RMSE root mean square error
Fig 5 BMI for age. BMI for age is plotted for ELBW infants. The shaded
areas represent the 25th–50th, 50–75th, and 75th–95th percentiles of the
WHO growth charts; ELBW function: General model Rat34: f(x) = (
p1*x^3 + p2*x^2 + p3*x + p4) /; (x^4 + q1*x^3 + q2*x^2 + q3*x + q4);
Coefficients (with 95% confidence bounds): p1 = 2361 (−1.199e+06,
1.203e+06); p2 = 87.87 (−4.044e+11, 4.044e+11); p3 = 857.6
(−1.361e+11, 1.361e+11); p4 = 225.7 (−1.909e+11, 1.909e+11); q1 =
7.852 (−1.713e+08, 1.713e+08); q2 = 1665 (−1.279e+09, 1.279e+09);
q3 = −4398 (−2.848e+11, 2.848e+11); q4 = −1901 (−8.607e+11,
8.607e+11); Goodness of fit: SSE: 9.316; R2: 0.9557; Adjusted R2:
0.8008; RMSE: 2.158; SSE sum of squared estimate of errors, RMSE root
mean square error
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beneficial for metabolic and cardiovascular diseases, hyperten-
sion, and renal function later in life or not [12, 19, 20, 30].
With regard to body composition and fat distribution in
ELBW infants, there remains some controversy. Studies do
not agree on differences in %LM, FM, %TBF and fat distri-
bution [17, 18, 30, 34, 35, 39].
It is suggested that an aberrant body composition with a
higher %TBF could indeed make ELBW infants and adoles-
cents more susceptible to cardiovascular diseases and insulin
resistance [17, 30, 34].
Nevertheless, there is a lack in information about the body
composition in former ELBW infants and it is possible that
differences in body composition and fat distribution only ap-
pear with advancing age, thus there is a need for longitudinal
studies [17]. There is also no agreement on the ideal measure
method to investigate body composition.
There are some limitations to this review as a result of the
inclusion of long-term follow-up studies and the comparison
of cases at different points of time.
Some of the study patients were born in the 1990s or ear-
lier. Perinatal care and nutritional practices have since
evolved, so one should be careful extrapolating these results
to the current population of ELBW neonates [17, 18].
Another consequence of including longitudinal follow-up
studies is a certain degree of loss of follow-up for part of the
subjects, which could cause bias in the remaining study
population.
Furthermore, because we did not have access to individual
growth data in the different studies, we focused on mean data.
Studies also use different definitions of SGA and often do not
compare the GA of SGA and AGA infants. This is an import
limitation, as SGA infants will have a higher GA per definition
and might therefore exhibit a different growth pattern.
Nevertheless, the results in most of the studies so far do not show
a significant difference in growth parameters between SGA and
AGA infants after the age of 8.6, but former SGA infants often
represent the smallest spectrum of ELBW infants later in life.
One more main limitation is the assessment at many different
time points and the heterogeneity of the study populations.
Future studies should investigate the correlation between
growth, weight gain, and adipose tissue development since
not only ELBW but also BMI is suggested to be a possible
influencer of body composition and related adverse health
outcomes [17].
Intervention studies should focus on proportional growth
and weight gain, especially from the age of 8 until the age of
14. However, increase in height and weight during this period
might be influenced by inadequate growth in the first years of
life. Also, catch-up growth for height and weight in the first 2
years of life might be beneficial for body composition later in
life [19, 20, 30, 36, 41]. Careful follow-up throughout child-
hood is therefore needed to optimize the growth patterns of
ELBW infants.
Conclusion
Studies consistently report that ELBW infants attain lower
growth parameters than NBW control patients after hospital
discharge throughout childhood and adolescence. Although
there seems to be a certain degree of catch-up growth for all
growth parameters, differences in anthropometric parameters
continue to exist with advancing age. Since catch-up growth is
often more pronounced for weight than for height, it is impor-
tant to strive for proportional growth in intervention studies.
There is a lack of studies investigating body composition in
ELBW infants. There is some evidence that they might have
an aberrant body composition, but studies do not draw uni-
form conclusions. Associations between body composition
and cardiovascular diseases are suggested. Further research
and longitudinal studies are needed to ascertain whether the
higher prevalence of metabolic and cardiovascular diseases
could indeed be a consequence of an aberrant growth pattern,
different body composition, or inadequate fat tissue
development.
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